Task: Answer the multiple-choice question.
Question: Which compound exhibits a -29.390% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a) CC(C)c1ccccc1NC(=S)N(C)C
b) CCOc1ccc(NC(=O)NNC(=O)C(C)Oc2ccccc2OC)cc1
c) c1ccc2c(c1)C(=NCC1CCCO1)NC2=NCC1CCCO1
d) O=C(O)C(=O)O.O=C1CC(Cc2ccccc2)C(=O)N1CCCn1ccnc1
e) O=C(NC1CCc2ccccc21)C1CCN(S(=O)(=O)c2ccc(-n3cnnn3)cc2)CC1
Answer: e. O=C(NC1CCc2ccccc21)C1CCN(S(=O)(=O)c2ccc(-n3cnnn3)cc2)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C(NC1CCc2ccccc21)C1CCN(S(=O)(=O)c2ccc(-n3cnnn3)cc2)CC1
O=C(NC1CCc2ccccc21)C1CCN(S(=O)(=O)c2ccc(-n3cnnn3)cc2)CC1
N-(2,3-dihydro-1H-inden-1-yl)-1-[4-(tetrazol-1-yl)phenyl]sulfonylpiperidine-4-carboxamide